Commission Implementing Regulation (EU) 2016/2045 of 23 November 2016 amending Regulation (EU) No 37/2010 as regards the substance gamithromycin
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
087/2017 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2016/2045 of 23 November 2016 amending Regulation (EU) No 37/2010 as regards the substance gamithromycin
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2016/2045 frá 23. nóvember 2016 um breytingu á reglugerð (ESB) nr. 37/2010 að því er varðar efnið gamítrómýsín
Durchführungsverordnung (EU) 2016/2045 der Kommission vom 23. November 2016 zur Änderung der Verordnung (EU) Nr. 37/2010 hinsichtlich des Stoffs Gamithromycin
Kommisjonens gjennomføringsforordning (EU) 2016/2045 av 23. november 2016 om endring av forordning (EU) nr. 37/2010 med hensyn til stoffet gamitromycin
History
06.05.2017
Adopted JCD confirmed entry into force date
06.05.2017
Compliance date in the EEA
05.05.2017
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
17.03.2017
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
23.11.2016
Adoption date in the EU
14.12.2016
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.